{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:01:26Z","timestamp":1783141286668,"version":"3.54.6"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,25]]},"abstract":"<jats:p>Hepcidin is an essential regulator of iron homeostasis in chronic kidney disease (CKD) anemia, reticulocyte hemoglobin equivalent (RET-He) can be used to evaluate the availability of iron for erythropoiesis. Previous research has found that hepcidin indirectly regulates RET-He. This study aimed to investigate the association of hepcidin, RET-He and anemia-related indicators on anemia in chronic kidney disease. A total of 230 individuals were recruited, including 40 CKD3-4 patients, 70 CKD5 patients without renal replacement therapy, 50 peritoneal dialysis patients, and 70 hemodialysis patients. The serum levels of hemoglobin (Hb), reticulocyte, RET-He, serum iron, serum creatinine, serum ferritin, total iron binding capacity, hepcidin-25, high sensitivity C-reactive protein, transferrin, erythropoietin, intrinsic factor antibody, soluble transferrin receptor and interleukins-6 (IL-6) were measured. Hepcidin-25 was positively associated with IL-6, and negatively with total iron binding capacity, intrinsic factor antibody, and transferrin. Reticulocyte Hb equivalent was associated positively with Hb, serum ferritin, serum iron, transferrin saturation, and negatively with serum creatinine, reticulocyte, IL-6, STfR. Hepcidin-25 was not associated with RET-He, while IL-6 was independently associated with hepcidin-25 and RET-He, suggesting that hepcidin has no effffect on the iron dynamics of reticulocytes in CKD, may be related to IL-6, indicate a likelihood of a threshold for stimulation of hepcidin-25 expression by IL-6 in order to indirectly regulates RET-He.<\/jats:p>","DOI":"10.1097\/md.0000000000033558","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:02:49Z","timestamp":1682690569000},"page":"e33558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Zhaoli","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Nephrology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[{"name":"Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medicine Experimental Center, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-2707","authenticated-orcid":false,"given":"Zhao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2009.09.001","article-title":"Anemia in renal disease: diagnosis and management.","volume":"24","author":"Lankhorst","year":"2010","journal-title":"Blood Rev"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/14712598.2014.892577","article-title":"New treatment approaches in chronic kidney disease-associated anaemia.","volume":"14","author":"Del Vecchio","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cqn.2012.06.003","article-title":"Anemia in chronic kidney disease patients.","volume":"1","author":"Somvanshi","year":"2012","journal-title":"Clin Queries Nephrol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00467-015-3284-2","article-title":"Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.","volume":"31","author":"Davidkova","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD.","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease.","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00467-017-3663-y","article-title":"Anemia in chronic kidney disease.","volume":"33","author":"Atkinson","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0973-7847.156333","article-title":"Hepcidin - a novel biomarker with changing trends.","volume":"9","author":"Kali","year":"2015","journal-title":"Pharmacogn Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e00192","DOI":"10.1042\/BSR20150014","article-title":"Hepcidin: regulation of the master iron regulator.","volume":"35","author":"Rishi","year":"2015","journal-title":"Biosci Rep"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"18975","DOI":"10.1074\/jbc.R115.650150","article-title":"Regulation of iron metabolism by hepcidin under conditions of inflammation.","volume":"290","author":"Schmidt","year":"2015","journal-title":"J Biol Chem"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12882-020-02046-7","article-title":"Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.","volume":"21","author":"Nalado","year":"2020","journal-title":"BMC Nephrol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000328037","article-title":"Renal anemia of inflammation: the name is self-explanatory.","volume":"32","author":"Yilmaz","year":"2011","journal-title":"Blood Purif"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"9071057","DOI":"10.1155\/2021\/9071057","article-title":"Reticulocyte hemoglobin equivalent: diagnostic performance in assessment of iron deficiency in patients with hypothyroidism.","volume":"2021","author":"Aslam","year":"2021","journal-title":"Anemia"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41372-019-0434-6","article-title":"Trends in reticulocyte hemoglobin equivalent values in critically ill neonates, stratified by gestational age.","volume":"39","author":"German","year":"2019","journal-title":"J Perinatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41390-018-0178-6","article-title":"Reticulocyte hemoglobin content as an early predictive biomarker of brain iron deficiency.","volume":"84","author":"Ennis","year":"2018","journal-title":"Pediatr Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1097\/MPH.0000000000001700","article-title":"Reticulocyte hemoglobin content (Ret He): a simple tool for evaluation of iron status in childhood cancer.","volume":"42","author":"Tantawy","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.4103\/1319-2442.308335","article-title":"Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.","volume":"31","author":"Sany","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R20-20250504","first-page":"34","article-title":"Concordance between reticulocyte hemoglobin equivalent and reticulocyte hemoglobin content in CKD patients undergoing hemodialysis.","volume":"49","author":"Wirawan","year":"2017","journal-title":"Acta Med Indones"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"239476","DOI":"10.1155\/2012\/239476","article-title":"Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients.","volume":"2012","author":"Eguchi","year":"2012","journal-title":"Int J Nephrol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000508561","article-title":"Plasma levels of hepcidin and reticulocyte haemoglobin during septic shock.","volume":"12","author":"Olinder","year":"2020","journal-title":"J Innate Immun"},{"key":"R23-20250504","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1880499","DOI":"10.1155\/2021\/1880499","article-title":"The implication of dropping race from the MDRD equation to estimate GFR in an African American-only cohort.","volume":"2021","author":"Yap","year":"2021","journal-title":"Int J Nephrol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/14728222.2019.1599358","article-title":"Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease.","volume":"23","author":"Malyszko","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2174\/0929867324666170316120538","article-title":"Role of hepcidin-25 in chronic kidney disease: anemia and beyond.","volume":"24","author":"Ueda","year":"2017","journal-title":"Curr Med Chem"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1681\/ASN.2020101476","article-title":"Will targeting interleukin-6 in the anemia of CKD change our treatment paradigm?","volume":"32","author":"Coyne","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ekir.2018.12.006","article-title":"Interleukin-6 contributes to the development of anemia in Juvenile CKD.","volume":"4","author":"Akchurin","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.mayocp.2020.10.042","article-title":"Using reticulocyte hemoglobin equivalent as a marker for iron deficiency and responsiveness to iron therapy.","volume":"96","author":"Auerbach","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R30-20250504","first-page":"31","article-title":"Usefulness of reticulocyte hemoglobin equivalent in management of regular hemodialysis patients with iron deficiency anemia.","volume":"54","author":"Dalimunthe","year":"2016","journal-title":"Rom J Intern Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/00365513.2012.735694","article-title":"Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia.","volume":"73","author":"Schoorl","year":"2013","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:00:42Z","timestamp":1746324042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":31,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033558","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}